“In the first in-depth look of its kind into physician use of public genAI tools, Fierce Healthcare spoke with nearly two dozen doctors, students, AI experts and regulators, and helped conduct a survey of more than 100 physicians. The reporting confirms that some doctors are turning to tools intended for non-clinical uses to make clinical decisions. With no standardized guidelines, lagging physician training and regulators racing to try to keep up with rapidly changing technology, guardrails to protect patients appear to be years behind current rates of utilization.”
The article references Atropos Health’s recently released paper on the results of ChatRWD™, the first generative AI application to deliver full observational studies on healthcare data in minutes, transforming the way you access evidence. ChatRWD beta outperformed ChatGPT 3.5, Google Gemini 1.5 Pro. and Anthropic Claude 3 on answers to clinical questions when reviewed by independent physicians. OpenEvidence also outperformed the “Big Tech” LLMs by a wide margin. Most importantly, ChatRWD performed highest on physician trust and providing the best answer and was able to answer questions asked 94% of the time.
As the Gen AI cycle continues to move at a rapid pace, trust and accuracy are going to be critical, and publishing performance on both is table stakes. After years of delivering just-in-time, publication grade, real-world evidence studies in under two days, Atropos Health continues to combine the latest LLMs with GENEVA OS™ (Generative Evidence Acceleration Operating System), the underlying platform containing the phenotype library to achieve our mission of accelerating the generation of actionable evidence to improve healthcare outcomes for everyone.